RE:RE:RE:Thanks West ---the Bull Case -Unoteable??Unoteable --- you have hit the nail on the head...and likely explained why insider and institutional ownership is so low. My Biotech analyst friend took a quick look at ONCY....gave us props for safety...but said the action of Pela thus far has been weak....just adding a few months to survivability here and there. He advised that Oncorus was a better play as their virus is getting stronger immune reactions and better survivability.....though with some additional side effects....he also commented that ONCY seemed to have a case of the "slows"....taking longer than most to move through the studies etc...I am holding a large position here...but may begin unwinding......the lack of insider ownership is such a red flag. I feel more comfortable owning companies like EMX where insiders have huge positions.....